Virtual Self-Management Program for JIA
- Sponsor
- University of Calgary
- Study ID
- NCT06184100
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Virtual Self-Management Program (SMP) — OTHERFour sessions, 60-90 minutes each, will be conducted over eight weeks with a group size of 4-6 participants via videoconferencing platforms such as Zoom or Microsoft Teams. Each session will include Power Point delivered presentations, interactive activities, and group discussions. This is a multifaceted program that includes JIA disease education, self-management strategies, and peer support.
- No Intervention — OTHERNo intervention. Participant only receives standard of care.
Study Details
The aim of this project is to conduct a pilot randomized controlled trial (RCT) to evaluate the feasibility and preliminary effectiveness of a virtual group based self-management program (SMP) in adolescents with JIA across different provinces compared to a wait-list control group receiving only standard of care. Participants in the SMP group will partake in four 60-90 minute group sessions conducted over 8 weeks. The intervention is a multifaceted program that includes JIA disease education, self-management strategies, and peer support. Both the interventional and control group will be asked to complete baseline and post-test measures. Participants in the control group will be offered the SMP after completion of the post-control outcome measures.
Key Dates
- Start date
- Dec 13, 2023
- Status verified
- Oct 2024
- Primary completion
- Dec 31, 2025
- Completion
- Mar 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: SMP Program with Standard Carefour 60-90 minute virtual educational sessions over 8 weeks with a group of 4-6 participants
- Active Comparator: Standard Care OnlyStandard of care(no formal education program similar to SMP) and placed on 8-week waitlist for optional intervention.
Primary Outcome Measure
Program Adherence Rates (feasability) [ Time Frame: 3 months ]
Central Contacts
- Heinrike Schmeling, MD, PhD403-955-7698
- Jessica Booth, BSc403-955-3194
Related Studies
- Development of a Therapeutic Endpoint in Pediatric Rheumatologic ConditionsRecruiting · Children's National Research Institute · Washington D.C., District of Columbia
- Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.PHASE3 · Recruiting · AbbVie · Phoenix, Arizona
- Pain in Juvenile ArthritisRecruiting · Washington University School of Medicine · St Louis, Missouri